Download PDF
Hamostaseologie 1985; 05(02): 65-74
DOI: 10.1055/s-0038-1655102
Originalarbeiten
Schattauer GmbH

Medikamentös bedingte Blutungskomplikationen in der internistischen Intensivmedizin

Th. Eckhardt
1   Zentrum für Innere Medizin (Gesch. Direktor: Prof. Dr. Dr. h. c. H. G. Lasch), Klinikum der Justus-Liebig-Universität Gießen
,
D. Heinrich
1   Zentrum für Innere Medizin (Gesch. Direktor: Prof. Dr. Dr. h. c. H. G. Lasch), Klinikum der Justus-Liebig-Universität Gießen
› Author Affiliations
Further Information

Publication History

Publication Date:
22 June 2018 (online)

Also available at
    Permissions and Reprints

 

 

  • LITERATUR

  • 1 Bechthold H, Andrassy K, Jähnchen E, Koderisch J, Koderisch H, Weilemann L. S, Sonntag H. G, Ritz E. Evidence for impaired hepatic vitamin K1 metabolism in patients treated with N-methyl-thiotetrazole cephalosporins. Thromb. Haemostas. 51: 358-361 1984;
    PubMedGoogle Scholar
  • 2 Brown C. H, Bradshaw H, Natelson E. A, Alfrey C. P, Williams T. W. Defective platelet function following the administration of penicillin compounds. Blood 47: 949-956 1976;
    PubMedGoogle Scholar
  • 3 Brown C. H, Natelson E. A, Bradshaw M. W, Alfrey C. P, Williams T. W. Study of the effects of ticarcillin on blood coagulation and platelet function. Antimicrob. Agents Chemother. 07: 652-657 1963;
    PubMedGoogle Scholar
  • 4 Brown C. H, Natelson E. A, Bradshaw M. W, Williams T. W, Alfrey C. P. The hemostatic defect produced by carbenicillin. New Engl. J. Med. 291: 265-270 1964;
    PubMedGoogle Scholar
  • 5 Cazenave J-P, Reimers H-J, Senyi A. F, Hirsh J, Packham M. A, Mustard J. F. Effects of penicillin G and cephalotin on platelet function in vivo. Proc. Soc. Exp. Biol. Med. 152: 141-144 1976;
    PubMedGoogle Scholar
  • 6 Chastre J, Cornud F, Bouchama A, Vian F, Benacerraf R, Gibert C. Thrombosis as a complication of pulmonary-artery catheterization via the internal jugular vein. Prospective evaluation by phlebography. New Engl. J. Med. 306: 278-281 1982;
    CrossrefPubMedGoogle Scholar
  • 7 Clancy C. M, Glew R. H. Hypoprothrombinaemia and bleeding associated with cephamandole. Lancet I: 250 1983;
    PubMedGoogle Scholar
  • 8 Clive D. M, Stoff J. S. Renal syndromes associated with nonsteroidal antiinflammatory drugs. New Engl. J. Med. 310: 563-572 1984;
    CrossrefPubMedGoogle Scholar
  • 9 Colman R. W, Robboy S. J, Minna J. D. Disseminated intravascular coagulation (DIC): An approach. Amer. J. Med. 52: 679-689 1972;
    CrossrefPubMedGoogle Scholar
  • 10 Copelan E. A, Kusumi R. K, Miller L, Fass R. J. A comparison of the effect of mezlozillin and carbenicillin on hemostasis in volunteers. J. Antimicr. Chemotherapy. 11 (Suppl. C): 43 1983;
    PubMedGoogle Scholar
  • 11 Deykin D. Hemorrhagic complications of drugs. In: Colman R. W, Hirsh J, Marder V. J, Salzman E. W. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Lippincott, Philadelphia, Toronto: 1982: 602-611.
    Google Scholar
  • 12 Deykin D. Uremic bleeding. Kidney Intern. 24: 698-705 1983;
    CrossrefPubMedGoogle Scholar
  • 13 Dijkmans B. A. C, van der Meer J. W. M, Boekhout-Mussert M. J, Zaalde-Jong M, Mattie H. Prolonged bleeding time during azlozillin therapy. J. Antimicrob. Chemother. 06: 554-556 1980;
    CrossrefPubMedGoogle Scholar
  • 14 Duckert F, Marbet G. A. Therapeutische Fibrinolyse (Thrombolyse). In: Koller F, Duckert F. Thrombose und Embolie. Schattauer, Stuttgart; New York: 1983: 423-448.
    Google Scholar
  • 15 Editorial: Antimicrobials and Haemostasis. Lancet I: 510-511 1983;
    PubMedGoogle Scholar
  • 16 European Cooperative Study Group of Streptokinase Treatment in Acute Myocardial Infarction: Streptokinase in acute myocardial infarction. New Engl. J. Med. 301: 797-802 1979;
    CrossrefPubMedGoogle Scholar
  • 17 Fainstein V, Bodey G, McCredie K, Keating M, Estey E, Bolivar R, Elting L. Coagulation abnormalities induced by beta lactam antibiotics in cancer patients. J. Infect. Dis. 148: 745-750 1983;
    CrossrefPubMedGoogle Scholar
  • 18 Feliciano D. V, Mattox K. L, Graham J. M, Beall A. C, Jordan G. L. Major Complications of percutaneous subclavian vein catheters. Amer. J. Surg. 138: 869-874 1979;
    CrossrefPubMedGoogle Scholar
  • 19 Foote G. A, Schabel S. I, Hodges M. Pulmonary complications of the flow-directed balloon-tipped catheter. New Engl. J. Med. 290: 927-931 1974;
    CrossrefPubMedGoogle Scholar
  • 20 Gardner F. H, Bessman J. D. Thrombocytopenia due to defective platelet production. Clin. Haematol. 12: 23-38 1983;
    PubMedGoogle Scholar
  • 21 Gardner R. M, Schwartz R, Wong H. C, Burke J. P. Percutaneous indwelling radialartery catheters for monitoring cardiovascular function. Prospective study of the risk of thrombosis and infection. New Engl. J. Med. 290: 1227-1231 1974;
    PubMedGoogle Scholar
  • 22 Gentry L. O, Jemsek J. G, Natelson E. A. Effects of sodium piperacillin on platelet function in normal volunteers. Antimicrob. Agents Chemother. 19: 532-533 1981;
    CrossrefPubMedGoogle Scholar
  • 23 Goldberg S, Greenspon A. J, Urban P. L. et al. Reperfusion arrhythmia: a marker of restoration of antegrade flow during intracoronary thrombolysis for acute myocardial infarction. Amer. Heart J. 105: 26-32 1983;
    CrossrefPubMedGoogle Scholar
  • 24 Goldenheim P. D, Kazemi H. Cardiopulmonary monitoring of critically ill patients (two parts). New Engl. J. Med. 311. 717-720: 776-780 1984;
    PubMedGoogle Scholar
  • 25 Haburchak D. R, Head D. R, Everett E. D. Postoperative hemorrhage associated with carbenicillin administration. Amer. J. Surg. 134: 630-634 1977;
    CrossrefPubMedGoogle Scholar
  • 26 Hooper C. A, Haney B. B, Stone H. H. Gastrointestinal bleeding due to vitamin K deficiency in patients on parenteral cefamandole. Lancet I: 39-40 1980;
    PubMedGoogle Scholar
  • 27 Hory B, Saint-Hillier Y, Perol J. C. Prostacyclin as the sole antithrombotic agent for acute renal failure hemodialysis. Nephron 33: 71 1983;
    CrossrefPubMedGoogle Scholar
  • 28 King D. J, Kelton J. G. Heparin-associated thrombocytopenia. Ann. Int. Med. 100: 535-540 1984;
    CrossrefPubMedGoogle Scholar
  • 29 Kirchhof B, van de Loo J. Fibrinolytische Behandlung bei akutem Herzinfarkt. Hämostaseologie 01: 33-39 1981;
    PubMedGoogle Scholar
  • 30 Laffel G. L, Braunwald E. Thrombolytic therapy: A new strategy for the treatment of acute myocardial infarction (two parts) New Engl. J. Med. 311 710-717: 770-776 1984;
    PubMedGoogle Scholar
  • 31 Lechner K, Niessner H, Thaler E. Coagulation abnormalities in liver disease. Sem. Thromb. Hemostas. 04: 50-56 1977;
    PubMedGoogle Scholar
  • 32 Lind S. E. Prolonged bleeding time. Amer. J. Med. 77: 305-312 1984;
    CrossrefPubMedGoogle Scholar
  • 33 Lipsky J. N-methyl-thio-tetrazole inhibition of the gamma carboxylation of glutamine acid: possible mechanism for antibiotic-associated hypoprothrombinemia. Lancet II: 192-193 1983;
    PubMedGoogle Scholar
  • 34 Mathey D. G, Schofer J, Kuck K-U, Bell U, Klöppel G. Transmural, haemorrhagic myocardial infarction after intracoronary streptokinase: clinical, angiographic and necropsy findings. Brit. Heart J. 48: 546-551 1982;
    CrossrefPubMedGoogle Scholar
  • 35 Matthews M. W, Kuhn J. L, Smalling R. W. et al. Incidence of bleeding complications associated with intracoronary streptokinase therapy for acute myocardial infarction. Circulation 68 Suppl. 3: III-292 abstr. 1983;
    PubMedGoogle Scholar
  • 36 McClure P. D, Casserly J. G, Monsier C, Crozier C. Carbenicillin-induced bleeding disorder. Lancet II: 1307-1308 1970;
    PubMedGoogle Scholar
  • 37 McMillan R. Immune thrombocytopenia. Clin. Haematol. 12: 69-88 1983;
    PubMedGoogle Scholar
  • 38 Natelson E. A, Brown C. H, Bradshaw M. W, Alfrey C. P, Williams T. W. Influence of cephalosporin antibiotics on blood coagulation and platelet function. Antimicrob. Agents Chemother 09: 91-93 1976;
    CrossrefPubMedGoogle Scholar
  • 39 Natelson E. A, Siebert W. T, Williams T. W, Bradshaw M. W. Combined effects of ticarcillin and cefazolin on blood coagulation and platelet function. Am. J. Med. Sei. 278: 207-227 1979;
    CrossrefPubMedGoogle Scholar
  • 40 Neu H. C. The new beta-lactamase stable cephalosporins. Ann. Int. Med. 97: 408-419 1982;
    CrossrefPubMedGoogle Scholar
  • 41 Neu H. C. Adverse effects of new cephalosporins. Ann. Int. Med. 98: 415-416 1983;
    PubMedGoogle Scholar
  • 42 Neuhaus K. L, Tebbe J. U, Sauer G, Köstering H, Kreuzer K. High dose intravenous streptokinase infusion in acute myocardial infarction. Eur. Heart J. 02 (Suppl. A): 144 abstr. 1981;
    PubMedGoogle Scholar
  • 43 Pape L. A, Haffajee C. I, Markis J. E, Ockene I. S, Paraskos J. A, Dalen J. E, Alpert J. S. Fetal pulmonary hemorrhage after use of the flow-directed balloon-tipped catheter. Ann. Int. Med. 90: 344-347 1979;
    CrossrefPubMedGoogle Scholar
  • 44 Pinnick R. V, Wiegmann T. B, Diedrich D. A. Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. New. Engl. J. Med. 308: 258-261 1983;
    CrossrefPubMedGoogle Scholar
  • 45 Rao A. K, Walsh P. N. Acquired qualitative platelet disorders. Clin. Haematol. 12: 201-238 1983;
    PubMedGoogle Scholar
  • 46 Rosenberg R. D. Heparin-AntithrombinSystem. In: Colman R. W, Hirsh J, Marder V. J, Salzman E. W. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Lippincott, Philadelphia Toronto: 1982: 962-985.
    Google Scholar
  • 47 Schröder, Biamino R. G, Enz-Rüdiger V. L. et al. Intravenous short-term infusion of streptokinase in acute myocardial infarction. Circulation. 67: 536-548 1983;
    CrossrefPubMedGoogle Scholar
  • 48 Sharma G. V. R. K, Cella G, Parisi A. F, Sasahara A. A. Thrombolytic therapy. New Engl. J. Med. 306: 1268-1276 1982;
    CrossrefPubMedGoogle Scholar
  • 49 Shattil S. J, Bennett J. S, McDonough M, Turnbull J. Carbenicillin and penicillin G inhibit platelet function in vitro by impairing the interaction of agonists with the platelet surface. J. Clin. Invest. 65: 329-337 1980;
    CrossrefPubMedGoogle Scholar
  • 50 Six P, Marbet G. A, Walter M, Nyman D, Duckert F, Madar G, da Silva A, Widmer L. K, Ritz R. Nebenwirkungen bei verschiedenen Thrombolysemethoden. In: Niehaus K, Duckert F. (Eds.): Blutgerinnung und Antikoagulation. Schattauer, Stuttgart; New York: 1976: 111.
    Google Scholar
  • 51 Somani P, Smith M. R, Gohara A, Kapila K. The effects of mezlocillin, ticarcillin and placebo on blood coagulation and bleeding time in normal volunteers. Antimicrob. Agents Chemother. 19: 532-540 1981;
    CrossrefPubMedGoogle Scholar
  • 52 Spann J. F, Sherry S, Carabello B. A. et al. Coronary thrombolysis by intravenous streptokinase in acute myocardial infarction: acute and follow-up studies. Amer. J. Cardiol. 53: 655-661 1984;
    CrossrefPubMedGoogle Scholar
  • 53 Swartz R. D. Hemorrhage during highrisk hemodialysis using controlled heparinization. Nephron. 28: 65-69 1981;
    CrossrefPubMedGoogle Scholar
  • 54 Swartz R. D, Port F. K. Preventing hemorrhage in high-risk hemodialysis: Regional versus low-dose heparin. Kidney Intern. 16: 513-518 1979;
    CrossrefPubMedGoogle Scholar
  • 55 van de Werf F, Ludbrook P. A, Bergmann S. R, Tiefenbrunn A. J, Fox K. A, de Geest H, Verstraete M, Collen D, Sobel B. E. Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction. New Engl. J. Med. 310: 609-613 1984;
    CrossrefPubMedGoogle Scholar
  • 56 Verstraete M, Vermylen J. Thrombosis. Pergamon Press; 1984
    Google Scholar
  • 57 Weinstein J. Treatment of myocardial infarction with intracoronary streptokinase: efficacy and safety data from 209 United States cases in the Hoechst-Roussel registry. Amer. Heart J. 104: 894-898 1982;
    CrossrefPubMedGoogle Scholar
  • 58 Weitekamp M. R, Aber R. C. Prolonged bleeding times and bleeding diathesis associated with moxalactam administration. JAMA. 249: 69-71 1983;
    CrossrefPubMedGoogle Scholar
  • 59 World J. S, Buening M. K, Hanasono G. K. Latamoxef-associated hypoprothrombinaemia. Lancet II: 408 1983;
    PubMedGoogle Scholar
  • 60 Zusman R. M, Rubin R. H, Cato A. E, Cocchetto D. M, Crow J. W, Tolkoff-Rubin N. Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent. New Engl. J. Med. 304: 934-939 1981;
    CrossrefPubMedGoogle Scholar